Skin wrote:MagicMatic wrote:Skin wrote:Or he could be our long term answer and we give him a new deal that fits his value.
The thing I'm waiting to see is if Paolo can end up being a good 3pt shooter. If he struggles, then yea, we'll need to trade Markelle. If Paolo does become a good 3pt threat, then I'm fine keeping Markelle.
I
Chances are Markelle is going to want more, not less, than his current deal. His deal isn't worth the value at all. The guy is hardly available to play. He's on a $17m/2yr and he's only played 98 games in 3 years with Orlando.
I would believe you if he showed some kind of elite skill. He hasn't. He's a marginal at best starter and should not be the teams second highest paid player. He hasn't proven anything in 3+ years with Orlando and 5 years in the league. It's also not like they couldn't fill his spot with guys already on the roster (Suggs and Cole).
I'd much rather move him than do what Orlando always does: overpay mediocre injury prone players like Markelle Fultz.
You don't think he has an elite handle? If you want an elite overall player, he'd be getting WAY MORE than $17/2yr contract. Right now h's the only player on the team who is a real playmaker for others. You find me someone better then I'm game. ...and no Suggs is not that guy. Dude struggles even dribbling the ball.
Suggs does something Fultz doesn’t, he plays defense.
No I don’t think Fultz has an elite handle. He’s an average playmaker, isn’t good defensively, doesn’t shoot, and can’t get to the line. He can create for himself sometimes when he actually plays. Cool. Totally worth being the third highest paid player on the roster…
I do think he’s elite at being injured and staying barely relevant in the league. He was the #1 pick that has played a little over one full season in 5 years.
You’re using 1 injured season worth of data to make proclamations on Suggs, who still played more in that year than Fultz did in his “injured” years. I’m using 5 years of data on Fultz.
